McDavid Stilwell
Nessuna posizione attualmente
Patrimonio netto: 179 979 $ in data 31/03/2024
Storia della carriera di McDavid Stilwell
Precedenti posizioni note di McDavid Stilwell
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| COHERUS BIOSCIENCES, INC. | Director of Finance/CFO | 08/03/2021 | 08/12/2023 |
| Investor Relations Contact | 01/10/2020 | 08/03/2021 | |
| Public Communications Contact | 01/10/2020 | 08/03/2021 | |
| OREXIGEN THERAPEUTICS, INC. | Investor Relations Contact | 01/03/2012 | 01/11/2016 |
| Public Communications Contact | 01/03/2012 | 01/11/2016 | |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Public Communications Contact | 01/01/2005 | 01/01/2012 |
| SANGAMO THERAPEUTICS, INC. | Investor Relations Contact | 01/11/2016 | - |
| Public Communications Contact | 01/11/2016 | - |
Formazione di McDavid Stilwell
| Harvard Business School | Masters Business Admin |
| St. John's College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Public Communications Contact | 4 |
| Investor Relations Contact | 3 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- McDavid Stilwell
- Esperienza
